Orpyx, NIH put digital foot monitoring to the test
By HME News Staff
Updated 10:25 AM CST, Mon November 17, 2025
CALGARY, Alberta – Orpyx Medical Technologies has announced that its sensory insoles, analytics platform and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH). The randomized controlled trial, “WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention,” will enroll 400 participants to test whether integrating digital foot monitoring into routine care can help reduce the incidence of diabetic foot ulcers, one of the most costly and serious complications of diabetes. “Supporting independent, peer-reviewed research is central to advancing care for people with diabetes,” said Dr. Breanne Everett, CEO and founder of Orpyx Medical Technologies. “We are honored that our platform has been selected for use in this NIH-funded trial, which will generate high-quality evidence to inform the role of digital tools in diabetic foot ulcer prevention.” The $5 million trial will be led by Johns Hopkins University School of Medicine, with collaborators from Keck Medicine of USC and the University of Utah Spencer Fox Eccles School of Medicine. Orpyx says it partners with VA Medical Centers, health systems and payers across North America to deliver clinically validated outcomes and cost savings at scale.
Comments